Renaissance Technologies - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 95 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$22,204
-1.6%
588,800
-1.0%
0.04%
+15.2%
Q2 2023$22,565
+54.8%
594,900
-0.8%
0.03%
+73.7%
Q1 2023$14,577
-18.0%
599,400
-2.0%
0.02%
-20.8%
Q4 2022$17,767
-99.9%
611,800
-5.4%
0.02%
-11.1%
Q3 2022$19,394,000
-21.6%
646,900
-5.5%
0.03%
-6.9%
Q2 2022$24,744,000
-15.7%
684,300
+0.9%
0.03%
-14.7%
Q1 2022$29,343,000
-15.9%
678,300
-2.5%
0.03%
-20.9%
Q4 2021$34,877,000
-23.9%
696,000
-3.4%
0.04%
-27.1%
Q3 2021$45,845,000
-13.6%
720,500
-2.3%
0.06%
-10.6%
Q2 2021$53,063,000
-4.5%
737,400
-2.1%
0.07%
-4.3%
Q1 2021$55,541,000
-3.6%
753,100
-4.1%
0.07%
+9.5%
Q4 2020$57,642,000
+36.7%
785,100
+2.1%
0.06%
+50.0%
Q3 2020$42,158,000
-13.6%
768,600
+4.8%
0.04%0.0%
Q2 2020$48,777,000
+19.7%
733,600
+10.2%
0.04%
+5.0%
Q1 2020$40,759,000
-24.8%
666,000
+8.0%
0.04%
-4.8%
Q4 2019$54,200,000
+23.5%
616,400
+6.0%
0.04%
+13.5%
Q3 2019$43,889,000
-7.1%
581,700
+5.2%
0.04%
-11.9%
Q2 2019$47,234,000
+2.4%
552,964
+29.6%
0.04%0.0%
Q1 2019$46,133,000
+43.3%
426,800
+12.2%
0.04%
+20.0%
Q4 2018$32,189,000
-1.1%
380,300
+14.9%
0.04%
+6.1%
Q3 2018$32,537,000
-44.9%
331,000
-39.6%
0.03%
+3.1%
Q2 2018$59,014,000
+128.6%
548,400
+109.8%
0.03%
+14.3%
Q1 2018$25,811,000
-2.5%
261,400
+3.4%
0.03%
-3.4%
Q4 2017$26,460,000
-11.5%
252,700
-4.7%
0.03%
-17.1%
Q3 2017$29,897,000
-1.5%
265,300
-2.0%
0.04%
-10.3%
Q2 2017$30,342,000
-15.0%
270,766
-11.6%
0.04%
-22.0%
Q1 2017$35,709,000
-38.1%
306,200
-44.1%
0.05%
-45.1%
Q4 2016$57,646,000
-17.2%
547,600
-13.1%
0.09%
-26.0%
Q3 2016$69,610,000
-23.0%
629,900
+1.4%
0.12%
-28.5%
Q2 2016$90,403,000
+28.5%
620,900
+26.4%
0.17%
+28.4%
Q1 2016$70,379,000
+0.9%
491,300
+8.9%
0.13%
-11.8%
Q4 2015$69,733,000
+14.7%
451,200
+6.0%
0.15%
+4.8%
Q3 2015$60,814,000
+1.6%
425,600
+2.2%
0.14%
+6.6%
Q2 2015$59,861,000
+3.9%
416,600
+2.0%
0.14%
+10.6%
Q1 2015$57,626,000
-3.6%
408,606
+1.3%
0.12%
-14.6%
Q4 2014$59,795,000
-2.1%
403,500
+1.6%
0.14%
-13.8%
Q3 2014$61,099,000
+17.4%
397,110
+7.0%
0.17%
+38.0%
Q2 2014$52,057,000
+74.7%
371,200
+38.3%
0.12%
+70.4%
Q1 2014$29,792,000
+27.9%
268,400
+14.0%
0.07%
+26.8%
Q4 2013$23,288,000
+43.8%
235,473
+10.5%
0.06%
+43.6%
Q3 2013$16,196,000
+77.5%
213,100
+30.6%
0.04%
+62.5%
Q2 2013$9,123,000163,2000.02%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 640,735$24,1628.90%
Eversept Partners, LP 255,323$9,628,2300.82%
Murchinson Ltd. 103,744$3,912,1860.50%
BRANDES INVESTMENT PARTNERS, LP 472,488$17,817,5220.35%
COWEN AND COMPANY, LLC 69,160$2,608,0230.18%
HARVEST MANAGEMENT LLC 7,106$267,9670.14%
Alpine Global Management, LLC 8,158$307,6380.08%
Inspire Advisors, LLC 10,695$403,3090.07%
Renaissance Technologies 588,800$22,2040.04%
Analyst IMS Investment Management Services Ltd. 13,557$5130.03%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders